03364nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020001500112020001800127020002700145040002100172035002100193050002500214082001900239245008200258260004600340300003800386490004800424504005100472505207100523533015202594650002102746655002902767700001802796710001702814830004202831856012602873999001502999ebr10693631CaPaEBRm        u        cr cn|||||||||050126s2009    nyuad   sb    001 0 eng d  z  2005002170  z1594542414  z9781594542411  z9781608766956 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)84494041814aRC280.O8bO93 2009eb04a616.99/46522200aOvarian cancerh[electronic resource] :bnew research /cA.P. Bardos, editor.  aNew York :bNova Biomedical Books,c2009.  axvii, 293 p. :bill. (some col.).1 aHorizons in cancer research series ;vv. 19  aIncludes bibliographical references and index.0 ach. 1. Progress in ovarian cancer research / Dilek Aktas -- ch. 2. Ovulation and ovarian surface epithelial cancer / William J. Murdoch and Anna C. McDonnel -- ch. 3. Ovarian sertoli-leydig cell tumors with heterologous elements / Evanthia Kostopoulou and Alexander Talerman -- ch. 4. Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer / G. Hudelist ... [et al.] -- ch. 5. Role of membrane-associated serine/threonine phosphatase in ovarian cancer cell survival : evidence for minor role of apoptosis in gonadotropin-releasing hormone's antiproliferative signaling / Atsushi Imai ... [et al.] -- ch. 6. Docetaxel in combination with carboplatin as first-line chemotherapy for patients with epithelial ovarian cancer / Yoichi Aoki and Kenichi Tanaka -- ch. 7. Immunospecific albumin microspheres as delivery system for cisplatin and 5-fluorouracil for the treatment of ovarian adenocarcinoma / Ernest J. Truter and Aldina S. Santos -- ch. 8. Strategies for improving outcome in ovarian cancer : the role of surgery / Karsten M�unstedt ... [et al.] -- ch. 9. Should systematic lymphadenectomy be performed in suboptimally debulked patients with stage III ovarian carcinoma? : a Degog study / Ugar Syagili ... [et al.] -- ch. 10. Outcomes for surgery in ovarian cancer / L. Elit -- ch. 11. Do ascites, mass volume and peritoneal carcinomatosis affect serum CA-125 levels in patients with ovarian carcinoma? : a different point of view / Ugar Saygili ... [et al.] -- ch. 12. The usefulness of serum CA-125 levels in the prediction of optimal primary cytoreduction in patients with advanced ovarian carcinoma / Ugar Syagili, Serkan Guclu and Oktay Erten -- ch. 13. Perceived risk of ovarian cancer, worry about ovarian cancer risk, and use of ovarian cancer screening by women at risk for ovarian cancer / M. Robyn Andersen ... [et al.] -- ch. 14. New strategy for the treatment of ovarian cancer with the aim to conquer chemoresistance / Junzo Kigawa ... [et al.] -- ch. 15. Treatment decision making in ovarian cancer / L. Elit.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aOvariesxCancer. 7aElectronic books.2local1 aBardos, A. P.2 aebrary, Inc. 0aHorizons in cancer research ;vv. 19.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10693631zAn electronic book accessible through the World Wide Web; click to view  c9586d9586